Xtl Biopharmaceuticals Ltd Stock Market Value
| XTLB Stock | USD 1.82 0.06 3.41% |
| Symbol | XTL |
XTL Biopharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.30) | Revenue Per Share | Return On Assets | Return On Equity |
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
XTL Biopharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XTL Biopharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XTL Biopharmaceutica.
| 04/24/2025 |
| 07/23/2025 |
If you would invest 0.00 in XTL Biopharmaceutica on April 24, 2025 and sell it all today you would earn a total of 0.00 from holding XTL Biopharmaceuticals Ltd or generate 0.0% return on investment in XTL Biopharmaceutica over 90 days. XTL Biopharmaceutica is related to or competes with Benitec Biopharma, BOS Better, ProPhase Labs, and Xenetic Biosciences. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical p... More
XTL Biopharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XTL Biopharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XTL Biopharmaceuticals Ltd upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.47 | |||
| Information Ratio | 0.1059 | |||
| Maximum Drawdown | 37.44 | |||
| Value At Risk | (7.58) | |||
| Potential Upside | 13.64 |
XTL Biopharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XTL Biopharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XTL Biopharmaceutica's standard deviation. In reality, there are many statistical measures that can use XTL Biopharmaceutica historical prices to predict the future XTL Biopharmaceutica's volatility.| Risk Adjusted Performance | 0.1246 | |||
| Jensen Alpha | 1.15 | |||
| Total Risk Alpha | (0.47) | |||
| Sortino Ratio | 0.1303 | |||
| Treynor Ratio | (1.21) |
XTL Biopharmaceuticals Backtested Returns
XTL Biopharmaceutica appears to be abnormally volatile, given 3 months investment horizon. XTL Biopharmaceuticals shows Sharpe Ratio of 0.11, which attests that the company had a 0.11 % return per unit of standard deviation over the last 3 months. By analyzing XTL Biopharmaceutica's technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please utilize XTL Biopharmaceutica's Mean Deviation of 5.51, downside deviation of 6.47, and Risk Adjusted Performance of 0.1246 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, XTL Biopharmaceutica holds a performance score of 8. The firm maintains a market beta of -0.84, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning XTL Biopharmaceutica are expected to decrease at a much lower rate. During the bear market, XTL Biopharmaceutica is likely to outperform the market. Please check XTL Biopharmaceutica's maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to make a quick decision on whether XTL Biopharmaceutica's historical returns will revert.
Auto-correlation | -0.5 |
Modest reverse predictability
XTL Biopharmaceuticals Ltd has modest reverse predictability. Overlapping area represents the amount of predictability between XTL Biopharmaceutica time series from 24th of April 2025 to 8th of June 2025 and 8th of June 2025 to 23rd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XTL Biopharmaceuticals price movement. The serial correlation of -0.5 indicates that about 50.0% of current XTL Biopharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
XTL Biopharmaceuticals lagged returns against current returns
Autocorrelation, which is XTL Biopharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XTL Biopharmaceutica's stock expected returns. We can calculate the autocorrelation of XTL Biopharmaceutica returns to help us make a trade decision. For example, suppose you find that XTL Biopharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XTL Biopharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XTL Biopharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XTL Biopharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XTL Biopharmaceutica stock over time.
Current vs Lagged Prices |
| Timeline |
XTL Biopharmaceutica Lagged Returns
When evaluating XTL Biopharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XTL Biopharmaceutica stock have on its future price. XTL Biopharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XTL Biopharmaceutica autocorrelation shows the relationship between XTL Biopharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in XTL Biopharmaceuticals Ltd.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether XTL Biopharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XTL Biopharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xtl Biopharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xtl Biopharmaceuticals Ltd Stock:Check out XTL Biopharmaceutica Correlation, XTL Biopharmaceutica Volatility and XTL Biopharmaceutica Alpha and Beta module to complement your research on XTL Biopharmaceutica. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.